Doxycycline causes regression of endometriotic implants: a rat model
Lab / animal
OA: closed
CC0
⤵ 12 in-corpus citations
AI-generated summary
Doxycycline treatment significantly reduced endometriotic implant size and MMP expression in a rat model, with low-dose Dox also decreasing IL-6 levels.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Doxycycline (Dox) has a number of non-antibiotic properties. One of them is the inhibition of matrix metalloproteinase (MMP) activity. The aim of this study was to assess the effects of Dox in a rat endometriosis model.
METHODS: Endometriosis was surgically induced in 40 rats by transplanting of endometrial tissue. After 3 weeks, repeat laparotomies were performed to check the implants and the animals were randomized into four groups: Group I, low-dose Dox (5 mg/kg/day); Group II, high-dose Dox (40 mg/kg/day); Group III, leuprolide acetate 1 mg/kg single dose, s.c.; and Group VI (controls), no medication. The treatment, initiated on the day of surgery and continuing for 3 weeks, was administered to the study groups. Three weeks later, the rats were euthanized and the implants were evaluated morphologically and histologically for immunoreactivity of MMP-2 and -9, and interleukin-6 (IL-6) concentration in the peritoneal fluid was assayed.
RESULTS: Treatment with leuprolide acetate, or high-dose or low-dose Dox caused significant decreases in the implant areas compared with the controls (P = 0.03, P = 0.006, and P = 0.001, respectively). IL-6 levels in peritoneal fluid decreased in Group I (P = 0.02) and Group III (P < 0.05). MMP H scores were significantly lower in the group that received low-dose Dox in both epithelial and stromal MMP-2 and -9 immunostaining when compared with the control group [P = 0.048, P = 0.002, P = 0.007 and P = 0.002, respectively, MMP-2 (epithelia), MMP-2 (stroma), MMP-9 (epithelia) and MMP-9 (stroma)].
CONCLUSIONS: Low-dose Dox caused regression of endometriosis in this experimental rat model.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (96)
- Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
- Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas via openalex
- Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane via openalex
- Association of interleukin-6 and estradiol with hepatocyte growth factor in peritoneal fluid of women with endometriosis via openalex
- Combination of estrogen and dioxin is involved in the pathogenesis of endometriosis by promoting chemokine secretion and invasion of endometrial stromal cells via openalex
- Differential interleukin-6 messenger ribonucleic acid expression and its distribution pattern in eutopic and ectopic endometrium via openalex
- Differential regulation of matrix metalloproteinase-3 gene expression in endometriotic lesions compared with endometrium via openalex
- Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget via openalex
- Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis via openalex
- Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis via openalex
- Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9 via openalex
- Expression of metalloproteinase-9 in ectopic endometrium in women with endometriosis via openalex
- Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis via openalex
- [Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in ectopic and eutopic endometrium] via openalex
- Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis via openalex
- Genistein causes regression of endometriotic implants in the rat model via openalex
- Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas via openalex
- Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients via openalex
- Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis via openalex
- Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis via openalex
- Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model via openalex
- Interferon-gamma (IFN-gamma) and interleukin-6 (IL-6) in peritoneal fluid and macrophage-conditioned media of women with endometriosis via openalex
- Interleukin-6: another piece of the endometriosis-cytokine puzzle via openalex
- Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium via openalex
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness via openalex
- Paracrine regulation of matrix metalloproteinase expression in endometriosis via openalex
- Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium via openalex
- Pathological evaluation of the rat endometriosis model via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial via openalex
- Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib via openalex
- Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis via openalex
- Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice via openalex
- Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis via openalex
- The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production via openalex
- W2053321628 via openalex
- W2066700182 via openalex
- W2073595123 via openalex
- W2073597522 via openalex
- W2079801336 via openalex
- W2079862741 via openalex
- W2081117740 via openalex
- W2102404503 via openalex
- W2102732690 via openalex
- W2111275713 via openalex
- W2111497869 via openalex
- W2112753909 via openalex
- W2116969857 via openalex
- W2117420688 via openalex
- W2117753922 via openalex
- W2120212237 via openalex
- W2124600315 via openalex
- W2128930486 via openalex
- W2133184547 via openalex
- W2136348600 via openalex
- W2143715300 via openalex
- W2151591273 via openalex
- W2161052815 via openalex
- W2165476491 via openalex
- W2171863626 via openalex
- W92822971 via openalex
- W4376544320 via openalex
- W119090754 via openalex
- W1262682589 via openalex
- W1497141930 via openalex
- W1886431664 via openalex
- W1938535455 via openalex
- W1968256243 via openalex
- W1969169755 via openalex
- W1971586374 via openalex
- W1972229497 via openalex
- W1973990678 via openalex
- W1975593847 via openalex
- W1975722608 via openalex
- W1976295332 via openalex
- W1979323310 via openalex
- W1979978633 via openalex
- W1981277384 via openalex
- W1981390055 via openalex
- W1984483611 via openalex
- W1987748412 via openalex
- W1990858735 via openalex
- W1999272236 via openalex
- W2012551574 via openalex
- W2016037432 via openalex
- W2019264775 via openalex
- W2020867804 via openalex
- W2030776545 via openalex
- W2031000899 via openalex
- W2031006686 via openalex
- W2031602204 via openalex
- W2035813865 via openalex
- W2036038049 via openalex
- W2038981906 via openalex
- W2050733976 via openalex
- W2051209405 via openalex
Cited by (13)
- Nano-based Innovations for Reimagining Endometriosis: Next-Gen Diagnostics and Therapeutics Toward Targeted and Transformative Therapy- A Comprehensive Review 2026
- Applications of nanomaterials in endometriosis treatment 2023
- The effect of carbamazepine, which increases oestrogen destruction, on the endometriotic implants; an experimental rat model 2021
- Doxycycline reduces MMP-2 activity and inhibits invasion of 12Z epithelial endometriotic cells as well as MMP-2 and -9 activity in primary endometriotic stromal cells in vitro 2019
- Influência da doxiciclina em endometriose experimentalmente induzida em ratas 2018
- Relevant human tissue resources and laboratory models for use in endometriosis research 2017
- A Prospective Randomized Experimental Study to Investigate the Eradication Rate of Endometriosis after Surgical Resection versus Aerosol Plasma Coagulation in a Rat Model 2016
- Emerging treatment of endometriosis 2015
- Effect of the non-specific matrix metalloproteinase inhibitor Doxycycline on endometriotic implants in an experimental rat model 2015
- The impact of endometriosis on fertility 2015
- Endometriosis 2013
- Therapeutic Efficiency of Tibolone in a Rat Endometriosis Model 2011
- Potential cures for endometriosis 2011
Source provenance
- europepmc
- last seen: 2026-10-13T06:10:10.580696+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:06:23.467768+00:00
- unpaywall
- last seen: 2026-10-13T06:25:51.201866+00:00
License: CC0
· commercial use OK